Luiz Eduardo Nunes UNG

Dr. Luiz Eduardo Nunes UNG

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
DRDaniel B. Roquini
Daniel B. Roquini
RCRamon M. Cogo
Ramon M. Cogo
AMAna C. Mengarda
Ana C. Mengarda
SMSusana F. Mazloum
Susana F. Mazloum
CMCristiane S. Morais
Cristiane S. Morais
JMJosue De Moraes
Josue De Moraes
The treatment and control of schistosomiasis, a neglected disease that affects more than 200 million people worldwide, rely on the use of a single drug, praziquantel. A vaccine has yet to be developed, and since new drug design and development is a lengthy and costly process, drug repurposing is a promising strategy. In this study, the efficacy of promethazine, a first-generation antihistamine, was evaluated against Schistosoma mansoni ex vivo and in a murine model of schistosomiasis.

15 August 2018 in International Journal of Dentistry
Verified
Journal Article
Open access
PDF file
ECEmily Chen
Emily Chen
BBBruna Benso
Bruna Benso
DSDalia Seleem
Dalia Seleem
LULuiz Eduardo Nunes UNG
Luiz Eduardo Nunes UNG
SPSilvana Pasetto
Silvana Pasetto
RMRamiro Murata
Ramiro Murata
Current treatments forCandida albicansinfection are limited due to the limited number of antifungal drugs available and the increase in antifungal resistance. Curcumin is used as a spice, food preservative, flavoring, and coloring agent that has been shown to have many pharmacological activities. Thus, this study evaluated the modulatory effects of curcumin on major virulence factors associated with the pathogenicity ofC. albicans. The minimum inhibitory concentration (MIC) of curcumin againstC. albicans(SC5314) was determined. Biofilm formation was quantified and the proteinase and phospholipase secretion was measured. The cytotoxicity was tested in oral fibroblast cells. A cocultured model was used to analyze the gene expression of proinflammatory cytokines (IL-1β, IL-1α, and IL-6) from host cells, as well SAP-1 and PLB-1 by RT-PCR. The MIC was between 6.25 and 12.5 µM, and the activity of proteinase enzyme was significantly decreased in biofilms treated with curcumin. However, proteinase gene expression was not downregulated after curcumin treatment. Furthermore, gene expressions of host inflammatory response, IL-1βand IL-1α, were significantly downregulated after exposure to curcumin. In conclusion, curcumin exhibited antifungal activity againstC. albicansand modulated the proteolytic enzyme activities without downregulating the gene expression. In host inflammatory response, curcumin downregulated IL-1βand IL-1αgene expression.

2 September 2023 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
LULuiz Eduardo Nunes UNG
Luiz Eduardo Nunes UNG
Michelle Franz-MontanMichelle Franz-Montan
Michelle Franz-Montan
BBBruna Benso
Bruna Benso
HGHarvinder S. Gill
Harvinder S. Gill
Oral cavity drug and vaccine delivery has the potential for local targeting, dose reduction, minimization of systemic side effects, and generation of mucosal immunity. To overcome current limitations of delivery into the oral cavity mucosa, microneedles (MNs) have emerged as a promising technology. We reviewed the literature on MN application in the oral cavity, including in vitro studies, in vivo animal studies, and human clinical trials. MNs are sufficiently robust to cross the oral cavity epithelium and nearly painless when applied to different parts of the human oral mucosa including the lip, cheek, tongue and palate. In recent years, MNs have been evaluated for different applications, including vaccination, topical anesthetic delivery, and treatment of local oral pathologies such as oral lesions or carcinomas. MNs are attractive because they have the potential to produce a better treatment outcome with reduced side effects. Over the coming years, we project a significant increase in research related to the development of MNs for use in dentistry and other medical conditions of the mouth.

29 December 2016 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Open access
PDF file
LULuiz Eduardo Nunes UNG
Luiz Eduardo Nunes UNG
BMBruno Vilela Muniz
Bruno Vilela Muniz
JBJonny Burga-Sánchez
Jonny Burga-Sánchez
MVMaria Cristina Volpato
Maria Cristina Volpato
Eneida De PaulaEneida De Paula
Eneida De Paula
FGFrancisco Carlos Groppo
Francisco Carlos Groppo
Objectives: Modified drug delivery systems have been developed to improve pharmacological properties of local anaesthetics. However, the inflammatory potential of these formulations was not investigated. This study compared the in-vitro effects of ropivacaine (ropi) in plain, liposomal (MLV) or 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) formulations on cell viability, apoptosis and cytokine (IL-1α, TNF-α, IL-6 and IL-10) release. Methods: Human immortalized keratinocytes (HaCaT) and human immortalized gingival fibroblasts (HGF) were exposed to 1–100 μm ropi concentrations. The cell viability was measured by XTT and LIVE/DEAD assay. Apoptosis was performed by flow cytometry, and cytokine release was measured by ELISA assay. Key findings: Human immortalized keratinocyte viability was reduced by ropi and both drug delivery systems. However, none of the formulations induced apoptosis. Results showed a differential regulation of IL-1α TNF-α, IL-6 and IL-10 by HaCaT and HGF. Ropi-HP-β-CD increased twofold the IL-6 release by HGF in comparison with the control, while 100 μm ropi-MLV led to an increased release of all pro-inflammatory cytokines by HGF. Conclusion: The loss in cell viability was not related to cellular apoptosis. Ropi complexed with HP-β-CD showed a similar cytokine release pattern when compared to the plain formulation. Thus, the HP-β-CD form was a better drug carrier than the MLV form for ropivacaine drug delivery.

4 November 2022 in Brain Research
Verified
Journal Article
Closed access
WHWagner Hummig
Wagner Hummig
DBDarciane Favero Baggio
Darciane Favero Baggio
RLRaphael Vieira Lopes
Raphael Vieira Lopes
SSSilmara Martins Dias dos Santos
Silmara Martins Dias dos Santos
LULuiz Eduardo Nunes UNG
Luiz Eduardo Nunes UNG
JCJuliana Geremias Chichorro
Juliana Geremias Chichorro

27 December 2022 in The Journal of Pain
Verified
Journal Article
Closed access
DBDarciane F. Baggio
Darciane F. Baggio
FLFernanda M.R. da Luz
Fernanda M.R. da Luz
RLRaphael V. Lopes
Raphael V. Lopes
LULuiz Eduardo Nunes UNG
Luiz Eduardo Nunes UNG
EAErika I. Araya
Erika I. Araya
JCJuliana G. Chichorro
Juliana G. Chichorro